In a previous study we demonstrated that the alternatively spliced region of tenascin-C, TNfnA-D, bound with high affinity to a cell surface receptor, annexin II. In the present study we demonstrate three changes in cellular activity that are produced by adding intact tenascin-C or TNfnA-D to cells, and we show that all three activities are blocked by antibodies against annexin II. 1) TNfnA-D added to confluent endothelial cells induced loss of focal adhesions. 2) TNfnA-D produced a mitogenic response of confluent, growth-arrested endothelial cells in 1% serum. TNfnA-D stimulated mitogenesis only when it was added to cells before or during exposure to other mitogens, such as basic fibroblast growth factor or serum. Thus the effect of TNfnA-D seems to be to facilitate the subsequent response to growth factors. 3) TNfnA-D enhanced cell migration in a cell culture wound assay. Antibodies to annexin II blocked all three cellular responses to TNfnA-D. These data show that annexin II receptors on endothelial cells mediate several cell regulatory functions attributed to tenascin-C, potentially through modulation of intracellular signalling pathways.
INTRODUCTION
Tenascin-C (TN-C) is a large extracellular matrix protein that is prominently expressed in many developing tissues but shows a restricted pattern of expression in adult tissues (Erickson and Bourdon, 1989) . However, enhanced TN-C expression has been observed in areas where active cell proliferation and tissue reorganization occur, in wound healing (Mackie et al., 1988; Whitby and Ferguson, 1991) , in regenerating nerve (Daniloff et al., 1989; Gatchalian et al., 1989) , and in a range of tumors (Chiquet-Ehrismann et al., 1986; Koukoulis et al., 1991) . Angiogenesis, including proliferation of endothelial cells and differentiation of new vessels, is essential for tissue reorganization in healing wounds and growing tumors. In glioblastoma multi-formes, TN-C is prominently associated with the hyperplastic blood vessels of the tumor, and much less with the adjacent normal blood vessels (Zagzag et al., 1995) . However, these immunohistochemical studies do not demonstrate any function for TN-C in the angiogenic process.
A previous study reported that endothelial cells lose focal adhesions in response to soluble TN-C (MurphyUllrich et al., 1991) . This rearrangement of the actin cytoskeleton is also seen when endothelial cells are treated with basic fibroblast growth factor (bFGF)l (Sato and Rifkin, 1988) , or phorbol esters (Schliwa et al., 1984) , where the loss of focal adhesions is accompanied by a mitogenic response. Two recent studies report contradictory results on how TN-C can affect the mitogenic response of cells. End et al. (1992) reported that TN-C was mitogenic for several cell types and that this activity was associated with a region in the fibronectin type III domains. In contrast, Crossin (1991) reported that TN-C inhibited the mitogenic response of 3T3 fibroblasts stimulated by growth factors.
TN-C expressed in healing wounds and in the stroma of malignant tumors usually includes the alternatively spliced segment, TNfnA-D, comprising fibronectin type III domains labeled A-D (Borsi et al., 1992; Zagzag et al., 1995) . We have found that TNfnA-D is the primary site for the binding of soluble TN-C to cells and it binds with high affinity to cell surface annexin II (Chung and Erickson, 1994) . The identification of annexin II as a receptor was surprising because annexin II has been well characterized as a cytoplasmic protein (Raynal and Pollard, 1994) , and it does not have a hydrophobic signal sequence for secretion. However, a number of recent papers have reported that annexins can be secreted to the extracellular phase by an unknown mechanism, and can be found on the surface of cells as a receptor for various proteins (see Chung and Erickson, 1994 , for references; also Hajjar et al., 1994) .
Does binding of TN-C to the annexin receptor induce any change in the activity of cells? In the present study, we studied three activities of cultured endothelial cells that are induced by addition of soluble TN-C: loss of focal adhesions, mitogenesis, and enhanced cell migration. Experiments demonstrate that all these activities are produced by the alternatively spliced segment TNfnA-D, and involve its interaction with the annexin II receptor.
MATERIALS AND METHODS Cells and Cell Cultures
The bovine endothelial cell line GM7373 (from Coriell Institute for Medical Research, Camden, NJ; originally described by Grinspan et al., 1983) , was produced by treating a primary fetal aortic endothelial cell clone, BFAlc, with benzopyrene. The bovine aortic endothelial (BAE) cells were isolated from aortas obtained at local abattoirs using collagenase according to established protocol and routinely cultured in Dulbecco's modified Eagle's medium, high glucose (DMEM) supplemented with 10% heat-inactivated fetal calf serum. BAE cells used for focal adhesion experiments were cultured in DMEM supplemented with 20% fetal calf serum (HyClone, Logan, UT), and then in serum-free medium for treatment with TN-C. Proteins and Antibodies TN-C was purified from culture supernatant of U-251 MG human glioma cells by gel filtration and mono Q ion exchange chromatography as described by Aukhil et al. (1990) . For the experiment in Figure 1B the large (HxB.L) and small (HxB.S) splice variants of native TN-C were purified from BHK cells transfected with the corresponding pNUT expression vectors (Aukhil et al., 1993) . Bacterial expression proteins were produced and purified as described by Aukhil et al. (1993) . The polyclonal antibody against annexin II was described in Chung and Erickson (1994) . Affinity-purified antiannexin II antibody was prepared on a column of 0.8 mg annexin II (purified from bovine lung) coupled to cyanogen bromide-activated Sepharose. Bound antibody was eluted with 0.1 M glycine, pH 2.6, and neutralized. All proteins and antibodies were dialyzed against D-TBS (20 mM tris, pH 7.4, 150 mM NaCl, 1 mM CaCl2, 1 mM MgCl2) and sterilized by filtering.
[3Hithymidine Incorporation Assay Bovine aortic GM 7373 endothelial cells were grown to confluence and then labeled with 0.1 ,uCi/ml ['4C]thymidine for 24 h. After (Figure 1 ). Thus TNfnA-D initiates its response by binding to the annexin II receptor, but the Hep-I peptide appears to interact with a different receptor. Figure 1B shows a repeat of this experiment using different preparations of all reagents, to demonstrate the reproducibility. In this experiment the annexin II antibody itself had no effect on focal adhesions (58% ± 1.5). We also tested separately the two splice variants of native TN-C. HxB.S, which is missing the alternatively spliced A-D domains, had no activity, and the activity of HxB.L was completely blocked by the annexin II antibody. Thus the effect of TN-C on focal adhesions is generated completely by the interaction of the TNfnA-D segment with the annexin II receptor. The loss of focal adhesions was also assayed by immunohistochemical staining for vinculin plaques (Figure 2) . In confluent endothelial cell cultures, about 40-50% of total cells showed prominent vinculin plaques at the periphery of the cell. Cells treated with TNfnl-5 or TNfn6-8 showed vinculin plaques identical to those of untreated cells, but in cultures treated with TN-C or TNfnA-D the number of cells with prominent vinculin plaques was greatly reduced. Phorbol myristate acetate induced a similar but stronger response, leading to a complete loss of vinculin plaques in all cells. Cells treated with TNfnA-D plus the affinity-purified anti-annexin II antibody showed vinculin plaques as prominent as the control cells.
A Mitogenic Activity of TN-C Mediated by Annexin II Because several growth factors produce a mitogenic response in addition to loss of focal adhesions, we tested TN-C for mitogenic activity on GM 7373, a transformed fetal aortic endothelial cell line. When confluent GM 7373 endothelial cells were incubated with various amounts of TN-C for 24 h, the incorporation of [3Hlthymidine was stimulated in a dosedependent manner (Figure 3 ). Although 20 ,ug/ml TN-C (which caused almost maximal loss of focal adhesions) gave only a small stimulation in this experiment, it induced significant mitogenesis in others. added to the cultures and incubated for 24 h. One percent fetal bovine serum was present throughout the experiment. After washing with phosphate-buffered saline, cells were harvested with 2% SDS and the radioactivity was determined. The ratio of 3H to 14C was used as an index for cell proliferation.
80-130% increase in growth when added to confluent GM 7373 endothelial cells in DMEM containing 1% fetal calf serum. The dose required for stimulation of mitogenesis is thus similar to or perhaps a bit larger than that inducing loss of focal adhesions. One should be cautious, however, in correlating the two responses, because the focal adhesion response was determined in serum-free medium, while the mitogenic response was measured in 1% serum, which partly inhibits the focal adhesion response.
A BrdU incorporation assay gave much more rapid labeling of proliferating cells, so it was used for the rest of our experiments. In this assay, cells were incubated with TN-C in the presence of 1% fetal calf serum for 12 h, and then labeled with BrdU for 2 h in the continued presence of TN-C. The number of nuclei labeled during a 2-h incubation with BrdU was around 10-15% of total nuclei visualized by 4',6-diamidino-2-phenylindole staining ( nuclei seemed to be distributed evenly. The mitogenic activity of whole TN-C was duplicated by TNfnA-D, but TNfnl-5, TNfn6-8, and TNfbg were inactive (Figures 4 and 5) .
The mitogenic responses of cells to TN-C and recombinant proteins was also examined in (nontransformed) BAE cells in which the focal adhesion disassembly activity of TN-C was originally described. As shown in Figure 5 , the basal level of labeling of BAE cells was only about half that of GM7373, but TN-C and TNfnA-D increased the level about 80-120%, which is very similar to the response of GM7373 cells. Thus, the mitogenic activity is not dependent on the transformed phenotype of GM 7373 endothelial cells.
The same concentrations of TN-C or TNfnA-D added to subconfluent GM 7373 endothelial cells showed no effect on cell growth (Figure 6 ). This result was interesting because most growth factors stimulate subconfluent cells more strongly than confluent ones. However, these cells are growing in the presence of 1% fetal calf serum, and 45% of the cells are labeled during the brief 2-h labeling period. They may therefore be maximally stimulated so that no growth factor or TN-C could further enhance their proliferation. We tested whether the mitogenic activity of TN-C might be mediated by the annexin II receptor. With both BAE cells and GM 7373 endothelial cells, the affinity-purified antibody against annexin II completely neutralized the activity of TN-C and TNfnA-D to stimulate the proliferation, whereas nonimmune IgG had no effect (Figure 7 ).
The Mitogenic Effect of TN-C Is Cooperative with a Growth Factor
Since the mitogenic activity of TN-C was always observed in the presence of serum, this raised the question of whether TN-C had its own mitogenic activity or was acting cooperatively with growth factors. When TN-C or TNfnA-D was added to confluent endothelial cells in the absence of serum or growth factor, there was no stimulation of cell proliferation (Figure 8) . Similarly, bFGF did not stimulate the confluent cells in the absence of TN-C or TNfnA-D (Figure 8 (Figure 8 facilitate the rapid response of cells to growth factors, rather than having a mitogenic activity of its own.
TN-C Enhances Cell Migration
We used an in vitro wound closure assay to test whether TN-C can affect the migration of GM 7373 cells. TN-C increased the migration of GM7373 endothelial cells into the denuded area at the wound edge about 80% (Figures 9 and 10 ). The active site was mapped to TNfnA-D by testing recombinant expression proteins (Figure 10 ). TNfnA-D stimulated the migration similarly to native TN-C, whereas cells treated with TNfnl-5 and TNfn6-8 showed basal level migration. TNfbg showed a moderate stimulation. The morphology of cells at the wound edge and in the monolayer of TN-treated culture was different from control cells. A large portion of cells in TN-C and TNfnA-D-treated cultures showed a more elongated morphology and appeared to be less flattened than the polygonal, cobblestone-like control cells (Figure 9 ). Cells treated with TNfnl-5, TNfn6-8, or TNfbg showed the same morphology as control cells. In previous studies of primary cultures of endothelial cells (Sato and Rifkin, 1988; Joyce and Meklir, 1992) , migrating cells moved ahead of the advancing wound edge as individuals, and retained minimal contacts with neighboring cells. Interestingly, migrating GM7373 cells at the wound edge maintained contacts with each other and we did not observe many individual cells ahead of the advancing monolayer. The contacts were generally looser in TN-C treated cultures, but even these cells retained contacts, and a migration edge was easily defined. Thus, the transformed GM7373 cells behave somewhat differently in this wound/migration assay, and their tendency to retain cell-cell contacts facilitated measurement of the migration rate.
The anti-annexin II antibody abolished the stimulatory effect of native TN-C and TNfnA-D on cell migration, but nonimmune IgG did not (Figure 10) . Thus, the increased migration of endothelial cells appears to result from the interaction of TNfnA-D with cell surface annexin II.
DISCUSSION
The three cellular responses to TN-C explored here were all mapped to the alternatively spliced segment, TNfnA-D, and we have now shown that all of these responses are mediated by the cell surface receptor, annexin II. At least three additional cellular responses to soluble TN-C have been mapped to TNfnA-D: inhibition of adhesion of uterine epithelial cells to Matrigel (Julian et al., 1994) ; inhibition of milk production by mammary epithelial cells (Jones et al., 1995) ; and inhibition of branching morphology of embryonic lung explants (Young et al., 1994) . It seems likely that these activities may also be mediated by TNfnA-D binding to annexin II, although it should be noted that the last two responses were also generated by other FN-III domains of TN-C.
Our work generally confirms and extends the study of End et al. (1992) T !~J q Figure 9 . The effect of TN-C on GM7373 cell migration tested in an in vitro wound closure assay.
One percent fetal calf serum was present before and after the wounding. TN-C (30 ,ug/ml), bacterial expression proteins 50 ,ug/ ml; TNfn6-8, 30 Ag/ml), and antibody (20 ,ug/ml) were added after wounding. The edge of the cell sheet was marked immediately after wounding (black arrows) and 48 h later (white arrows). Bar, 100 /.,m.
The primary response of cells to TN-C may be the down-regulation of focal adhesions and associated cytoskeleton. This response was first demonstrated with endothelial cells (Murphy-Ullrich et al., 1991) , and has been confirmed with both endothelial and smooth muscle cells (Hahn et al., 1995) . Growth factors alone also cause loss of focal adhesions, and this may be necessary to permit subsequent events of cell division, or cell migration. The role of TN-C in mitogenesis might be to facilitate this initial disruption of focal adhesions and associated cytoskeleton, thereby augmenting the effectiveness of growth factors. Since focal adhesions need to be broken to permit cell migration, the ability of TN-C to augment migration might also be due to its effect on focal adhesions. However, we have not yet determined the cell cycle point affected by TN-C and subsequently by bFGF. Preliminary study shows that our newly confluent endothelial cell cultures are not completely quiescent (GO/Gl); some cells are still cycling and in G2/M. A more extensive analysis will be needed to determine cell cycle points affected by TN-C, and whether the modulation of cytoskeleton is a primary factor in facilitating growth factor response.
Pretreatment of cells with TN-C permitted a rapid (2 h) response to bFGF. A rapid response to bFGF can also be obtained by pre-activating protein kinase C with phorbol ester, which also causes complete loss of focal adhesions and alterations in actin fibers (Schliwa et al., 1984; Hedberg et al., 1991) . KT (Chen et al., 1993; Demange et al., 1994) (Folkman et al., 1989) . It is primarily the large splice variant of TN-C that is expressed in wounds and tumors (Borsi et al., 1992) , which allows the possibility that TN-C may play a role in the initial stages of angiogenesis. It must be noted that wound healing was apparently normal in mice lacking TN-C (Saga et al., 1992) . However, a detailed study of wound healing in these mice has not been reported, nor has any study of tumor development. Changes in angiogenesis that alter but do not prevent wound healing, as well as alterations in tumor growth, need to be carefully examined in these mutant mice without tenascin.
